Human central nervous system pharmacology of pentamethylmelamine and its metabolites
Data up to Jan 2025
Total Citations Per Year
Abstract
References (19)
Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer Drugs
1978 • 982 citations
Vascular structures in brain tumors
1975 • 239 citations
Review lecture. The blood‐brain barrier.
1976 • 213 citations
Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors.
1982 • 195 citations
The Blood Brain Barrier
1971 • 183 citations
In vitro studies with hexamethylmelamine
1977 • 81 citations
Hexamethylmelamine—A new drug with activity in solid tumors
1973 • 77 citations
Comparative permeability of different glioma models to horseradish peroxidase.
1981 • 41 citations
Variable oral absorption of hexamethylmelamine in man.
1978 • 39 citations
Penetration of N-(phosphonacetyl)-L-aspartate into human central nervous system and intracerebral tumor.
1980 • 36 citations
Penetration of methylglyoxal bis(guanylhydrazone) into intracerebral tumors in humans.
1981 • 36 citations
Penetration of 3-deazauridine into human brain, intracerebral tumor, and cerebrospinal fluid.
1979 • 30 citations
Phase I trial of pentamethylmelamine: a clinical and pharmacologic study.
1981 • 13 citations
Pharmacology of pentamethylmelamine in humans.
1981 • 11 citations
Early clinical trial of a 1-day intermittent schedule for pentamethylmelamine.
1980 • 9 citations
Cerebrospinal fluid levels of hexamethylmelamine and N-demethylated metabolites.
1981 • 9 citations
Phase I trial of pentamethylmelamine.
1982 • 6 citations
Hexamethylmelamine and pentamethylmelamine tissue distribution in M5076/73A ovarian cancer-bearing mice.
1982 • 5 citations
High-performance liquid chromatographic analysis of pentamethylmelamine and its metabolites in biological fluids
1981 • 5 citations
Cited By (0)
No citing papers found in database